Cost-effectiveness acceptability curve for QALYs. nork Lotte Verweij (725951)

Gaiak:

Cost-effectiveness plane for QALYs comparing the intervention group to the usual care group. nork Lotte Verweij (725951)

Gaiak:

Cost-effectiveness plane for estimated readmission or mortality comparing the intervention group with the usual care group. nork Lotte Verweij (725951)

Gaiak:

Differences in readmission or mortality, QALYs and costs in €, ICERs, distribution of bootstrapped cost-effect pairs over the quadrants of the CE-plane, and the probability of cost... nork Lotte Verweij (725951)

Gaiak:

Cost-effectiveness acceptability curve for readmission or mortality. nork Lotte Verweij (725951)

Gaiak:

CCB intervention costs (€). nork Lotte Verweij (725951)

Gaiak:

Unadjusted mean costs (€) and effects over 6 months follow-up after multiple imputation. nork Lotte Verweij (725951)

Gaiak:

Baseline characteristics. nork Lotte Verweij (725951)

Gaiak:

Healthcare costs (€) used in the cost-effectiveness analysis. nork Lotte Verweij (725951)

Gaiak:

Flowchart. nork Lotte Verweij (725951)

Gaiak:

Unadjusted primary outcome measures. nork Paula Elisabeth van Westrienen (15195132)

Gaiak:

Adjusted multivariate comparisons of primary and secondary outcome measures per group based on intention-to-treat analysis at 3 and 12 months. nork Paula Elisabeth van Westrienen (15195132)

Gaiak:

Overview of the PARASOL intervention. nork Paula Elisabeth van Westrienen (15195132)

Gaiak:

Characteristics of participants^a. nork Paula Elisabeth van Westrienen (15195132)

Gaiak:

Flow chart. nork Paula Elisabeth van Westrienen (15195132)

Gaiak:

Unadjusted effects of retention in care period on treatment standards achievement, exposed (>50% of allowable time), unexposed (< = 50%), N = 211. nork John E. Deaver (19470090)

Gaiak:

Formation of the cohort of low‐income Peruvians with type 2 diabetes (DM) and/or hypertension (HTN). nork John E. Deaver (19470090)

Gaiak:

Probabilities of guidelines‐based treatment standards achievement, by program exposure (’post’ versus ’pre’). nork John E. Deaver (19470090)

Gaiak:

Unadjusted effects of exposures on treatment standards achievement. nork John E. Deaver (19470090)

Gaiak:

Predicted probabilities of guidelines‐based treatment standards achievement, by retention in care period (>50% versus < = 50% of allowable time for care period). nork John E. Deaver (19470090)

Gaiak: